CONFERENCE ON CRAMS IN PHARMA & BIOTECH 2 December ...

lunchlexicographerΒιοτεχνολογία

1 Δεκ 2012 (πριν από 4 χρόνια και 11 μήνες)

538 εμφανίσεις



CONFERENCE ON CRAMS IN PHARMA & BIOTECH
INDIA: The end to end solution provider.


2 December 2011, Jacaranda Hall, India Habitat Center, New Delhi

DRAFT PROGRAMME

0800 –0930 hrs Registration
1000-1100 hrs Inaugural Session

Welcome Address
Rajesh Jain
Chairman, CII national committee on Biotechnology &
Joint Managing Director, Panacea Biotec Ltd.
Address
Devendra Chaudhry
Joint Secretary
Department of Pharmaceuticals
Address
Renu S. Parmar
Adviser ( Ind/ VSE)
Planning Commission
Address
Amarendra Sinha
Joint Secretary & Development Commissioner- MSME
Ministry of Micro, Small & Medium Enterprises.
Address
Rajeev Kher
Additional Secretary
Department of Commerce & Industry.
Vote of Thanks
Abhaya Kumar
Chairman, CII Subcommittee on CRAMS &
Managing Director, Shashun Pharmaceuticals Ltd.
1100-1115 Tea /Coffee
Session: I Overview of CRAMS in India
1115-1315 Session Chairman: K Raghavendra Rao
Chairman & Managing Director
Orchid Chemicals & Pharmaceuticals Ltd.
“Opportunities and Challenges of running a CRAMS business from
India.”
Speaker: Manoj Mehrotra
Head- Global CPS Business
Dr Reddys Laboratories Limited

“Evaluating the size and growth potential of the gl obal contract
manufacturing industry to identify new opportunities for Indian
players.”
Speaker: Anil Khubchandani
Vice President & GU Head - Exclusive Synthesis
Jubilant Life Sciences Ltd.
Kiran S Divi
Director
Divi’s Laboratories Ltd

• Growing business- New opportunities & partnerships in
Manufacturing.
Speaker: Jay R Vyas,
Managing Director,
Dishma Pharma
Speaker: S.G Belapure,
President
Cadila Healthcare Ltd.

• Biotherapeutics- the new booming CMO segment.

Speaker: Sandeep Rao
Vice president- BD & Head-CRAMS
Biocon Ltd

Dr. Durgaprasad Annavajjula
Sr. VP R&D,
Kemwell Biopharma Private Ltd.

1315-1400 Lunch Break
Session II Contract Research
1400-1600
Session Chairman : Vinita Sharma
Advisor & Head-National Good Laboratory Practice

(GLP) Compliance Monitoring Authority
Department of Biotechnology

• Discovery research: Comes all the way to India.

Speaker: Raman Govindarajan
Head India R&D
Member Asia Pacific R&D Team
Sanofi Aventis Ltd.

Somesh Sharma
Managing Director
Piramal Life Sciences

• Preclinical research in India- Way forward- new avenues &
requirement

Speaker: Rashmi Barbhaiya,
Chief Executive Officer
Advinus Therapeutics Ltd.

Manu Jaggi,
Director,
Dabur Research Foundation

• Indian Clinical research industry- Opportunity to become global
Player.
Speaker: Apurva Shah,
Chairman ACRO & Managing Director,
Veeda Cr.
Suneela Thatte,
Executive Director,
Quintiles Research (India) Pvt. Ltd.
1600-1615 Tea /Coffee
1615-1800
Panel on “Regulatory & Policy interventions.”
Individual companies face different hurdles while performing their day to day
operations. The panel would be the right forum for them to interact and seek
remedies for the hindrances faced by them. The panel members would being with
brief introduction on the key initiatives taken up by their respective departments to
facilitate growth of the sector.


Chairman: Om Prakash
Member Secretary
National Pharmaceutical Pricing Authority

• Export- Import challenges
Speaker: Awaiting Nomination
Directorate General Foreign Trade
• Good manufacturing practices and Quality products work hand in
hand.
Speaker: Kathleen Holloway,
Regional Advisor- EDM
WHO-India

• Effective trade policy- Booster for Business promotion and
overcome international competition.
Speaker: J. S Deepak
Joint Secretary
Department of Commerce.

• On time delivery of product save business – on time Regulatory
approval is the key.
Speaker: V. G. Somani,
Drug Controller General of India
Center for Drugs
• Role of MoMSME in promotion of growth of Pharma SMEs
Speaker: Samarendra Sahu
Additional Development Commissioner
Ministry of Micro, Small & Medium Enterprises

Close